AgomAb Therapeutics AGMB
NASDAQ AGMB
$9.11 +0.38 (+4.35%)
At close: Oct 21, 2026 · 4:00 PM EDT

AgomAb Therapeutics NV (AGMB) Other Non-Current Liabilities (2024 - 2026)

Updated

Agomab Therapeutics' Other Non-Current Liabilities came in at $7.83 million for Q2 2026.

Analysis

AgomAb Therapeutics NV (AGMB) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Agomab Therapeutics' Other Non-Current Liabilities was $7.37 million, down 13.5% from FY2024.

  • Going back by year, Other Non-Current Liabilities was $8.53 million in FY2024.
  • The Q2 2026 figure represents the highest quarterly Other Non-Current Liabilities since Q4 2024.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.93 Mn
Dec 31, 2025 3.77 Mn
Dec 31, 2024 8.20 Mn
API Access

AgomAb Therapeutics NV Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AGMB&period=max&api_key=YOUR_API_KEY